| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,663 |
9,309 |
$431K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,940 |
6,037 |
$352K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
856 |
835 |
$55K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,595 |
1,403 |
$49K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,028 |
862 |
$25K |
| 93000 |
|
1,230 |
1,210 |
$12K |
| 99215 |
Prolong outpt/office vis |
161 |
156 |
$11K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
951 |
911 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
46 |
45 |
$3K |
| 81003 |
|
2,754 |
2,544 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
188 |
187 |
$2K |
| 99408 |
|
132 |
132 |
$2K |
| 99490 |
Ccm add 20min |
403 |
313 |
$2K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
641 |
618 |
$2K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
313 |
280 |
$1K |
| 90688 |
|
86 |
86 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
45 |
41 |
$1K |
| 99483 |
Prolong outpt/office vis |
16 |
13 |
$886.51 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
142 |
104 |
$868.75 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
135 |
134 |
$868.55 |
| J7050 |
Infusion, normal saline solution, 250 cc |
569 |
478 |
$474.92 |
| 90662 |
|
49 |
46 |
$390.07 |
| 1170F |
|
1,975 |
1,741 |
$371.00 |
| 96127 |
|
223 |
219 |
$342.43 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
76 |
72 |
$342.28 |
| 92588 |
|
15 |
15 |
$237.64 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
17 |
16 |
$196.35 |
| 1159F |
|
1,385 |
1,238 |
$185.00 |
| 99441 |
|
16 |
15 |
$183.21 |
| 1126F |
|
848 |
771 |
$180.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
244 |
200 |
$136.92 |
| 1125F |
|
772 |
701 |
$112.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
185 |
147 |
$102.22 |
| 3288F |
|
980 |
891 |
$84.65 |
| 99050 |
|
14 |
14 |
$58.05 |
| 36415 |
Collection of venous blood by venipuncture |
24 |
20 |
$50.04 |
| G0008 |
Administration of influenza virus vaccine |
27 |
27 |
$36.84 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
12 |
12 |
$36.09 |
| 3074F |
|
32 |
29 |
$14.00 |
| 3078F |
|
35 |
33 |
$12.00 |
| 3077F |
|
35 |
25 |
$10.00 |
| 3014F |
|
912 |
809 |
$8.00 |
| 3079F |
|
30 |
26 |
$8.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,179 |
846 |
$8.00 |
| 3061F |
|
32 |
27 |
$6.00 |
| 3072F |
|
14 |
13 |
$2.00 |
| 3044F |
|
12 |
12 |
$2.00 |
| 3060F |
|
15 |
13 |
$1.00 |
| 1036F |
|
2,435 |
2,175 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
370 |
311 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
463 |
418 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,976 |
1,777 |
$0.00 |
| 3017F |
|
1,218 |
1,011 |
$0.00 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
85 |
70 |
$0.00 |
| 4037F |
|
14 |
12 |
$0.00 |
| 1101F |
|
87 |
63 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
118 |
83 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
32 |
30 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,125 |
986 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,843 |
1,664 |
$0.00 |
| 3342F |
|
312 |
275 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
214 |
173 |
$0.00 |
| G8399 |
Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed |
171 |
128 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
105 |
88 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
116 |
76 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
86 |
81 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
90 |
77 |
$0.00 |
| 99072 |
|
13 |
12 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
32 |
25 |
$0.00 |